Vernalis hit by fresh U. S. setback for cough and cold drug
Shares in Vernalis fell more than 15 percent on Monday as the British biotech company backed by fund manager Neil Woodford and his previous employer Invesco announced a fresh setback for a key new drug in the United States.
Following is a summary of current health news briefs.
Vernalis hit by fresh U.S. setback for cough and cold drug
Shares in Vernalis fell more than 15 percent on Monday as the British biotech company backed by fund manager Neil Woodford and his previous employer Invesco announced a fresh setback for a key new drug in the United States. The company said its cough and cold treatment CCP-08 had received a so-called complete response letter (CRL) from the Food and Drug Administration (FDA), meaning the agency is not prepared to approve it at this time.
Dutch may need to cull millions of hens after contamination
Millions of hens may need to be culled in the Netherlands after traces of a potentially harmful insecticide were found in eggs, a Dutch farming group said, ratcheting up the strain on a sector still reeling from a bird flu outbreak. Retailers in several European countries have pulled millions of eggs from supermarket shelves as the scare over the use of insecticide fipronil widened, though Dutch industry group LTO said consumers were no longer at risk.
Zynerba's cannabis-based epilepsy gel fails study, shares plunge
Zynerba Pharmaceuticals Inc said on Monday its synthetic cannabis-based gel to treat epilepsy failed a mid-stage study, sending the U.S. drug developer's shares plunging 50 percent. In the study, two doses of Zynerba's gel — also its lead experimental drug — were tested in adults suffering from epilepsy with partial seizures, those that occur when epileptic activity takes part in a localized part of the brain.
(This article has not been edited by DNA's editorial team and is auto-generated from an agency feed.)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
)
){kind=small}
){kind=small}
)
)
)
)
)
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}